Recurrent Epithelial Ingrowth Research Articles

Successful YAG Laser Treatment for Epithelial Ingrowth in Descemet Stripping Endothelial Keratoplasty Interface

Purpose: To present a case of epithelial ingrowth in the graft–host interface after Descemet stripping endothelial keratoplasty (DSEK) surgery that was successfully treated with an Nd:YAG Laser. Methods: A 79-year-old Caucasian female underwent a repeat DSEK 9 months after a prior DSEK graft rejection and subsequent failure. At her regularly scheduled 1-month follow-up visit, an asymptomatic dense white interface opacity was observed within the stromal interface, with an appearance consistent with epithelial ingrowth. The depth and location was confirmed by anterior segment optical coherence tomography. After initial observation, the opacity was noted to be growing over 2 months. The epithelial ingrowth cells were then treated with an Nd:YAG Laser. Results: The patient remained stable 12 months post laser treatment with no recurrence of epithelial ingrowth. Focal stromal pits were noted at the site of Nd:YAG Laser treatment within the DSEK graft stromal interface, but were not visually significant. Conclusions: Nd:YAG laser treatment is a safe and effective way to treat early-stage epithelial ingrowth in the interface after DSEK surgery.

Surgical management of epithelial ingrowth following traumatic lamellar laceration of the cornea

We report a case of epithelial ingrowth (EI) after traumatic corneal lamellar laceration in a 57-year-old woman with a history of corneal trauma on her left eye (LE) 1 month before. On examination, best-corrected visual acuity (BCVA) was counting fingers at 1 m. Slit-lamp biomicroscopy showed a partial thickness corneal laceration with an undisplaced flap with EI within the flap–stroma interface. Since the EI affected the visual axis, we performed mechanical debridement. BCVA of the LE improved to 0.6 at 1 year postoperatively without recurrence of EI and with good flap apposition. We conclude that timely surgical debridement of posttraumatic EI can result in a favorable visual outcome.

Clinical outcomes of epithelial ingrowth following laser in situ keratomileusis with mechanical debridement and compressed heating air flow: a case series.

To describe the clinical outcomes of manual scraping of epithelial ingrowth followed by compressed heating air flow after laser in situ keratomileusis (LASIK). We underwent a retrospective, noncomparative, and interventional case series. Twenty eyes of 17 patients were included in this study. Each patient with a history of LASIK underwent epithelial removal with mechanical debridement followed by compressed heating air flow. Our primary outcome was the recurrence of epithelial ingrowth after 3 months of follow-up, while our secondary outcomes were uncorrected distance visual acuity, corrected distance visual acuity, and complications after surgery. Ten patients (58.8%) were male, and eight eyes of seven (41.2%) patients underwent primary LASIK surgery, while12 eyes of 10 patients had flap-lift retreatment LASIK; sixteen eyes (80.0%) underwent mechanical microkeratome LASIK and four (20.0%) underwent femtosecond laser-assisted LASIK. Mean age at surgical removal of epithelial ingrowth was 37.0 years ± 9.3 years (range 24 to 55 years). There was recurrence of ingrowth in two eyes (10%) after 3 months of follow-up. The mean corrected distance visual acuity of patients before surgery was 0.07 ± 0.09 logMAR, and after the last follow-up was 0.02 ± 0.04 logMAR (p=0.06). The odds ratio of presenting with epithelial ingrowth after LASIK enhancement compared to primary LASIK was 29.41. Manual scraping followed by compressed heating air flow is a safe and effective treatment of clinically significant epithelial ingrowth after LASIK. At the last follow-up, no eye lost any line in corrected distance visual acuity.

Nd:YAG laser for epithelial ingrowth after laser in situ keratomileusis.

To evaluate the efficacy of neodymium:yttrium-aluminum-garnet (Nd:YAG) laser for treatment of epithelial ingrowth after laser in situ keratomileusis (LASIK). Fifty-eight patients with epithelial ingrowth presented to Sohag refractive center, Sohag, Egypt, between January 2015 and March 2017. Only 41 patients (18 females and 23 males, mean age: 33.4years) involving 41 eyes were indicated for treatment by Nd:YAG laser as the rest of the eyes were only under observation. Patients with epithelial ingrowth were recognized at a mean of 6months after primary LASIK procedure (range: 2-16months). Four eyes had undergone previous LASIK enhancements. Four eyes had the epithelial ingrowth removed by flap lift and scrapping. The mean intensity of the spots used was 0.8mJ with variable number of shots depending on the size and density of the epithelial ingrowth area. Twenty-eight eyes showed complete regression after one session, while the rest necessitated 2-3 sessions for complete resolution. Mean follow-up period was 8months (range 5-12months). Epithelial ingrowth was treated successfully in all 41 eyes. The uncorrected visual acuities were 20/20, and there was no evidence of recurrent epithelial ingrowth after 6months with no complications reported. YAG laser is a simple, effective outpatient procedure for the management of epithelial ingrowth after LASIK.

Epithelial ingrowth after LASIK: visual and refractive results after cleaning the interface and suturing the lenticule.

The aim was to study the visual and refractive results in patients with epithelization in the corneal interface after laser in situ keratomileusis (LASIK) who were treated by cleaning the corneal interface (epithelial cyst extraction) and suturing the corneal flap. This is a retrospective, noncomparative interventional case series. The main outcome measures were uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), refractive cylinder (CYL), spherical equivalent (SE), recurrence of epithelial ingrowth, and complications. From a total of 7520 LASIK refractive eyes, 13 eyes with epithelial ingrowth were treated. The mean age was 46.9 years. The mean preoperative logMAR UDVA was 0.34 (SD, 0.19). At 2 months, the mean postoperative logMAR UDVA was 0.18 (SD, 0.17) and at 1 year was 0.12 (SD, 0.18) (P = 0.01). The mean logMAR CDVA before surgery was 0.16 (SD, 0.16). Two months and 1 year postoperatively, the mean logMAR CDVA was 0.05 (SD, 0.08) and 0.03 (SD, 0.06), respectively (P = 0.03). The mean SE before surgery was 0.30 D (SD, 1.09). The mean SE 2 months and 1 year after surgery was -0.07 (SD, 0.53) and -0.004 (SD, 0.18), respectively (P = 0.04). The mean CYL before surgery was -0.92 D (SD, 1.09); and the mean CYL 2 months and 1 year after surgery was -0.60 (SD, 0.84) and -0.18 (SD, 0.75), respectively (P = 0.26). No epithelial ingrowth recurrence was observed up to 1 year after epithelial removal. Cleaning the corneal interface and suturing the corneal flap was effective and appeared safe in treating epithelial ingrowth after LASIK, with an extremely low rate of regrowth. However, further prospective controlled studies with a longer follow-up are needed.

Fibrin glue for prevention of recurrent epithelial ingrowth under a LASIK flap with a central buttonhole defect

A 61-year-old woman presented with a paracentral buttonhole flap defect associated with a linear tear, extensive epithelial ingrowth, and macrostriae in the right eye. A laser in situ keratomileusis enhancement had been performed 3 weeks earlier. The epithelial ingrowth was removed after careful lifting of the flap, and tissue adhesive was used postoperatively as a barrier to further ingrowth. Six months postoperatively, the patient's corrected distance visual acuity had improved to 20/20 and the slitlamp examination showed no evidence of recurrent epithelial ingrowth. This case presents a novel approach to the management of a buttonhole defect.

Epithelial Ingrowth After LASIK: Clinical Characteristics, Risk Factors, and Visual Outcomes in Patients Requiring Flap Lift

To describe clinical characteristics, risk factors, and visual outcomes in patients requiring flap lift for epithelial ingrowth following LASIK. Consecutive, noncomparative, retrospective case series of eyes requiring flap lift for epithelial ingrowth following LASIK from June 2003 through July 2011 at a tertiary care, university-based eye hospital. Main outcome measures were uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) at 1 and 3 months and recurrence of epithelial ingrowth. Forty-five eyes were included. Laser in situ keratomileusis retreatment was the most common etiologic factor for epithelial ingrowth (28/45 eyes [62%]). All patients were treated with flap lift and scraping. Mean logMAR UDVA at presentation was 0.28 (Snellen equivalent 20/38). Mean logMAR UDVA at 3 months was 0.17 (Snellen equivalent 20/30) with 53% of eyes 20/25 or better. Mean logMAR CDVA at 3 months was 0.06 (Snellen equivalent 20/23) with 78% of eyes 20/25 or better. Epithelial ingrowth into the central cornea portended a trend towards UDVA worse than 20/25 or worse at 3-month follow-up (hazard ratio [HR] 5.54, 95% confidence interval [CI]: 0.98-31.3, P=.05) and CDVA worse than 20/25 at 3-month follow-up (HR 4.32, 95% CI: 0.85-21.9, P=.08). Recurrence after treatment was 31% at 3 months and 36% at 1 year. Risk factors for recurrence included: infectious etiology of ingrowth (HR 5.7, 95% CI: 1.11-29.1, P=.04), use of microkeratome for primary LASIK (HR 4.64, 95% CI: 1.07-20.1, P=.04), and hyperopic primary LASIK (HR 2.49, 95% CI: 0.98-6.31, P=.06). Patients undergoing flap lift for the treatment of epithelial ingrowth have a relatively high rate of recurrence but good visual acuity outcomes.

Successful Treatment of Recurrent Epithelial Ingrowth Associated with Interface Fluid Syndrome, Flap Necrosis, and Epithelial Defects Following LASIK

to report the successful treatment of two patients who developed flap necrosis preceded by recurrent epithelial ingrowth and interface fluid syndrome after LASIK. patient 1 was treated with epithelial debridement and flap suturing. Patient 2 was initially treated with epithelial debridement and flap suturing, but developed recurrent epithelial ingrowth in the right eye and 2 weeks later in the left eye. patient 1 developed diffuse interface fluid accumulation in the left eye after epithelial debridement and flap suturing and was treated with timolol meleate 0.5% solution and methazolamide. The interface fluid resolved and the cornea and flap became clear. Slit-lamp examination identified a small area of epithelial ingrowth recurrence, which has remained stable for 3 years. Patient 2 was successfully retreated with epithelial debridement followed by fibrin tissue adhesive application. Five months after debridement and fibrin tissue adhesive, no recurrence of epithelial ingrowth or interface fluid accumulation was noted. epithelial ingrowth and interface fluid syndrome may be associated with secondary flap necrosis following LASIK, which can be effectively treated with debridement and flap suturing or fibrin tissue adhesive application.

Topography-Guided Transepithelial Surface Ablation in Treatment of Recurrent Epithelial Ingrowths

To describe a new, single-step, transepithelial and trans-LASIK flap topography-guided surface ablation technique in a case of recurrent epithelial ingrowth with visual disturbances caused by irregular astigmatism, scattering, and decreased corneal transparency after LASIK. Custom ablation through both the epithelium and the LASIK flap performed by 1-kHz flying spot excimer laser was used to transform an irregular corneal surface into a regular aspheric surface and in the same continuous process to ablate the epithelial ingrowth causing the irregularity. Visual rehabilitation was achieved, the corneal surface was regularized, and epithelial ingrowth was removed within the ablation. The transepithelial topography-guided surface ablation technique was safe and effective in this case of visually disturbing epithelial ingrowth after LASIK, and may also be applied to treat other types of flap/interface complications.

Epithelial Ingrowth Within the Interface Following Traumatic Corneal Lamellar Laceration

A 45-year-old patient with a traumatic corneal lamellar laceration who was treated conservatively initially developed an epithelial ingrowth within the flap-stroma interface, causing diminished vision. Confocal microscopy revealed highly refractive bodies without cellular elements at the flap-stroma interface. Treatment comprised surgical debridement of the epithelial sheet from the interface with a thorough irrigation of the stromal bed followed by careful realignment of the flap. The diagnosis was confirmed by histologic examination of the scraped specimen. At the last follow-up examination, vision had improved and there was no recurrence of epithelial ingrowth. Proper primary management of a traumatic corneal lamellar laceration can provide good visual outcome and prevent rare complications such as epithelial ingrowth.

Amniotic membrane as a biologic pressure patch for treating epithelial ingrowth under a damaged laser in situ keratomileusis flap

We present 2 patients who had epithelial ingrowth after intraoperative laser in situ keratomileusis (LASIK) complications that created defects in the flap near the visual axis. As an adjuvant to removing the epithelium, an amniotic membrane patch was sutured tightly to the episclera so that it covered the entire cornea. The amniotic membrane overlay was left in place for about 1 week. There was no evidence of recurrent epithelial ingrowth after a minimum of 4 months. Use of an amniotic membrane overlay can be an effective adjuvant therapy to secure a LASIK flap when direct suturing would threaten the visual axis.

Mitomycin-C assisted photorefractive keratectomy in the treatment of buttonholed laser in situ keratomileusis flaps associated with epithelial ingrowth

The prophylactic intraoperative use of mitomycin-C (MMC) to prevent haze and scarring after excimer laser surface ablation (phototherapeutic/photorefractive keratectomy [PTK/PRK]) in an eye with a previous laser in situ keratomileusis (LASIK) flap buttonhole with epithelial ingrowth is described. A well-centered buttonhole measuring 2.0 mm in diameter was cut within a thin LASIK flap in an amblyopic eye. Over the next 8 weeks, corneal haze and progressive epithelial ingrowth formed centrally. An early transepithelial PTK/PRK approach was chosen to manage the buttonhole together with the epithelial ingrowth and to treat ametropia before the onset of scarring. The approach included epithelial removal with PTK, application of MMC 0.02% for 1 minute, irrigation, a short waiting period to allow for diffusion, PRK correction of -4.0 diopters without nomogram adjustment, and bandage contact lens. A regimen of prednisolone acetate 1% and ofloxacin 0.03% 5 times a day for 1 week (steroid tapered) was prescribed. Epithelial ingrowth was removed successfully. Minimal haze formation was visible 2 weeks after the retreatment but did not reduce best spectacle-corrected visual acuity (BSCVA) and resolved within the next few weeks. After 6 weeks, uncorrected visual acuity was equal to BSCVA preoperatively (20/50). There was no evidence of recurrent epithelial ingrowth or central scarring after 24 months. Transepithelial PTK/PRK was effective in managing central epithelial ingrowth in a buttonholed LASIK flap. Prophylactic intraoperative use of MMC may reduce haze formation and corneal scarring in early treatments and may also prevent recurrent epithelial ingrowth. This approach may offer faster visual recovery and no risk for a repeated buttonhole creation compared with the widespread recutting a new flap after a couple of months. The optimal application time and concentration of MMC need to be established.

Primary graft failure associated with epithelial downgrowth: a case report

BackgroundEpithelial downgrowth is a rare complication of ocular surgery. While the features of epithelial downgrowth following corneal transplantation are well described, its association with primary graft failure has only been reported once previously. We report a case of primary corneal graft failure (PGF) associated with retrocorneal epithelial cell ingrowth.Case presentationA 59 year-old male underwent an uncomplicated penetrating keratoplasty for Fuchs' corneal dystrophy. The patient developed PGF, and a second transplant was performed 5 weeks after the initial surgery. The initial host corneal button and the failed corneal graft were examined with light microscopy. Histopathologic examination of the excised corneal button demonstrated multilaminar epithelial cells on the posterior corneal surface and absence of endothelial cells. DNA extraction and polymerase chain reaction (PCR) for herpes simplex virus (HSV) DNA was performed on the failed corneal graft. Polymerase chain reaction performed on the failed corneal graft was negative for HSV DNA, which has been implicated in selected cases of PGF. Three years following repeat penetrating keratoplasty, there was no evidence of recurrent epithelial ingrowth.ConclusionThis is only the second report of PGF associated with epithelialization of the posterior corneal button, which most likely developed subsequent to, instead of causing, the diffuse endothelial cell loss and primary graft failure.

Flap suturing with proparacaine for recurrent epithelial ingrowth following laser in situ keratomileusis surgery

To evaluate the safety and efficacy of flap suturing with proparacaine application for the management of recurrent epithelial ingrowth following laser in situ keratomileusis (LASIK). Private consultation practice and Department of Ophthalmology, Rush University, Chicago, Illinois, USA. Six eyes of 5 patients with recurrent epithelial ingrowth had flap lifting followed by debridement of interface epithelial cells, interface application of proparacaine, and the placement of interrupted 10-0 nylon sutures. Four eyes achieved a best corrected visual acuity (BCVA) of 20/40 or better. Two eyes required repeat debridement with suturing and were stable with at least a 1-year follow-up. No eye lost more than 1 line of BCVA. Three eyes regained excellent uncorrected visual acuity due to a reduction in induced astigmatism. Recurrent epithelial ingrowth following LASIK surgery can be a visually debilitating condition. Flap suturing with interface proparacaine application may be effective in preventing further recurrences of epithelial ingrowth after initial debridement.

Laser in situ keratomileusis induced corneal perforation and recurrent corneal epithelial ingrowth

We report a rare complication of recurrent corneal epithelial cell ingrowth after corneal perforation induced by laser in situ keratomileusis. A corneal flap was made uneventfully with an automatic SCMD microkeratome (Howard Instruments, Inc.). During laser ablation, instead of random burning over the stromal bed, repeated ablation at a single location occurred because of a machine malfunction, resulting in corneal perforation. The flap was replaced and sutured to prevent leakage of aqueous humor. As the cornea healed, the patient's vision was compromised by scar formation, high irregular astigmatism, and epithelial ingrowth. The flap was reopened, and the epithelial cells were removed by thoroughly scraping the flap and stromal bed. However, corneal epithelial ingrowth recurred within a week. The recurrent and progressive epithelial ingrowth further decreased vision, and penetrating keratoplasty was recommended.

Risk factors in interface epithelialization after laser in situ keratomileusis.

To identify risk factors associated with primary and recurrent epithelial ingrowth after laser in situ keratomileusis (LASIK) requiring surgical debridement. Charts of patients who required single or multiple surgical debridements of epithelial ingrowth were reviewed retrospectively and analyzed to identify preoperative, intraoperative, and postoperative risk factors. Fourteen of 22 patients had epithelial ingrowth that required a single surgical removal. These were mostly associated with the surgeon's learning curve, epithelial injury, and enhancement by lifting the flap. Multiple surgical debridements were required in eight patients and some of these were associated with epithelial basement membrane degeneration and a history of type I diabetes. Refractive surgeons should be aware of surgical and non-surgical ocular and systemic risk factors associated with both primary and recurrent epithelial ingrowth after LASIK to appropriately consent patients seeking refractive surgery. Type I diabetes may increase the risk of epithelial downgrowth in LASIK.

Fibrin glue for the prevention of epithelial ingrowth after laser in situ keratomileusis

We present 3 cases of recurrent epithelial ingrowth following laser in situ keratomileusis. All patients consented to flap lifting, epithelial ingrowth removal, and placement of fibrin glue (Tisseel® VH, Baxter) at the flap edges. Two of 3 eyes had no evidence of recurrent epithelial ingrowth within a relatively short follow-up. One eye that also had had radial keratotomy had a small nest of stable epithelial cells that had not progressed. Fibrin glue may be a useful adjunct to prevent recurrent epithelial ingrowth. There were no complications associated with its use.